Cargando…
Donor-specific cell-free DNA as a biomarker in liver transplantation: A review
Due to advances in modern medicine, liver transplantation has revolutionised the prognosis of many previously incurable liver diseases. This progress has largely been due to advances in immunosuppressant therapy. However, despite the judicious use of immunosuppression, many liver transplant recipien...
Autores principales: | McClure, Tess, Goh, Su Kah, Cox, Daniel, Muralidharan, Vijayaragavan, Dobrovic, Alexander, Testro, Adam G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708879/ https://www.ncbi.nlm.nih.gov/pubmed/33312892 http://dx.doi.org/10.5500/wjt.v10.i11.307 |
Ejemplares similares
-
Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
por: Cox, Daniel R. A., et al.
Publicado: (2023) -
The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation
por: Goh, Su Kah, et al.
Publicado: (2019) -
Clinical and financial impacts of abnormal liver biochemistry after liver transplantation
por: Lim, Dee Zhen, et al.
Publicado: (2023) -
Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant
por: Chapman, Brooke, et al.
Publicado: (2019) -
Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up
por: McClure, Tess, et al.
Publicado: (2020)